Clin2
NCT06551337Worth exploringRecruiting

Vitamin D for bronchiectasis patients

Bronchiectasis

Treatments studied

Part of Lungs & breathing clinical trials.

This trial tests if taking vitamin D can help people with bronchiectasis have fewer flare-ups. It is only for patients who were in an earlier study that checked their vitamin D levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
104 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • 18 years or older
  • Diagnosed with bronchiectasis (not from cystic fibrosis) confirmed by a CT scan
  • Took part in the earlier vitamin D study (UW 22-317) at Queen Mary Hospital
  • No asthma, COPD, or other chronic lung disease
  • No osteoporosis
  • Not already taking vitamin D supplements
  • No advanced kidney disease (eGFR less than 30)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07523165Not yet recruiting· Phase 2
Chinese Herbal Medicine for Stable Bronchiectasis

This trial tests a Chinese herbal medicine called Lifei Qingchang Granules to see if it can help prevent flare-ups in people with bronchiectasis (a lung condition where airways are damaged and collect mucus). The study focuses on people whose condition is currently stable but who have had at least one flare-up in the past year.

Guangzhou, Guangdong
NCT07201051Recruiting· Phase 2
Testing a new drug for people with bronchiectasis

This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.

Mobile, Alabama
NCT06166056Recruiting· Phase 1/Phase 2
Testing an inhaled medicine for bronchiectasis safety

This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.

Cambridge
NCT06872892Recruiting· Phase 3
Study of BI 1291583 for people with bronchiectasis

This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.

Birmingham, Alabama
NCT07599839Recruiting
Study of bronchiectasis severity and flare-up risk

This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.

Asyut, Asyut Egypt
NCT06344000Recruiting
Nutrition and disease progression in bronchiectasis

This study looks at how nutrition affects the course of bronchiectasis, a lung condition that causes coughing and frequent infections. It may help find ways to slow the disease down.

Wuhan, Hubei

Hear when a new Bronchiectasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.